| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 2,245,000 | 2,273,000 | 2,436,000 | 2,650,000 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 2,245,000 | 2,273,000 | 2,436,000 | 2,650,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,291,000 | 2,778,000 | 2,213,000 | 2,213,000 | | Non Recurring | 603,000 | 218,000 | 2,000 | 173,000 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (649,000) | (723,000) | 221,000 | 264,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (649,000) | (723,000) | 221,000 | 264,000 | | Interest Expense |
-
| 72,000 | 69,000 | 64,000 | | Income Before Tax | (649,000) | (795,000) | 152,000 | 200,000 | | Income Tax Expense | (70,000) | (290,000) | 3,000 | 75,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (579,000) | (505,000) | 149,000 | 125,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| (1,000) |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (579,000) | (505,000) | 148,000 | 125,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($579,000) | ($505,000) | $148,000 | $125,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
